apomine intermittent apomorphine hydrochloride hemihydrate 30mg/3ml injection cartridge
interpharma pty ltd - apomorphine hydrochloride hemihydrate, quantity: 10 mg - injection, solution - excipient ingredients: sodium metabisulfite; water for injections; sodium hydroxide; hydrochloric acid - apomorphine injection is indicated to reduce the number and severity of "off" phases in patients with parkinson's disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine injection should be undertaken by a specialist unit in a hospital setting. conventional therapy should be continued during "on" phases.
apowok apomorphine hydrochloride hemihydrate 10 mg/ml solution for injection or infusion ampoule
wockhardt bio pty ltd - apomorphine hydrochloride hemihydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium hydroxide; hydrochloric acid; water for injections - apowok solution for injection or infusion is indicated to reduce the number and severity of ?off? phases in patients with parkinson?s disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during ?on? phases.
apomorphine wockhardt apomorphine hydrochloride hemihydrate 10 mg/ml solution for injection or infusion ampoule
wockhardt bio pty ltd - apomorphine hydrochloride hemihydrate, quantity: 10 mg/ml - injection, solution - excipient ingredients: sodium metabisulfite; sodium hydroxide; hydrochloric acid; water for injections - apomorphine wockhardt solution for injection or infusion is indicated to reduce the number and severity of ?off? phases in patients with parkinson?s disease severely disabled by motor fluctuations refractory to conventional therapy. initiation of therapy with apomorphine should be undertaken in a specialist unit in a hospital setting. conventional therapy should be continued during ?on? phases.
dbl papaverine hydrochloride 30mg/1ml injection
pfizer australia pty ltd - papaverine hydrochloride -
papaverine hydrochloride solution for injection
open joint stock company "borisovskiy zavod medicinskikh preparatov" - papaverine (papaverine hydrochloride) - solution for injection - 20mg/ml
papaverine hydrochloride solution for injection
open joint stock company "borisovskiy zavod medicinskikh preparatov" 64 - papaverine (papaverine hydrochloride) - solution for injection - 20mg/ml
papaverinum-injeel forte liq (4d,12d,30d,200d/1.1ml) liquid
biologische heilmittel heel gmbh - papaverine - liquid - 4d - papaverine 4d - homeopathic products
papaverinum-injeel liq liquid
biologische heilmittel heel gmbh - papaverine; papaverine; papaverine - liquid - 12d; 30d; 200d - papaverine 12d; papaverine 30d; papaverine 200d - homeopathic products
papaverine hydrochloride injection, solution
oryza pharmaceuticals inc. - papaverine hydrochloride (unii: 23473ec6bq) (papaverine - unii:daa13nkg2q) - papaverine is recommended in various conditions accompanied by spasm of smooth muscle, such as vascular spasm associated with acute myocardial infarction (coronary occlusion), angina pectoris, peripheral and pulmonary embolism, peripheral vascular disease in which there is a vasospastic element, or certain cerebral angiospastic states; and visceral spasm, as in ureteral, biliary, or gastrointestinal colic. intravenous injection of papaverine is contraindicated in the presence of complete atrioventricular heart block. when conduction is depressed, the drug may produce transient ectopic rhythms of ventricular origin, either premature beats or paroxysmal tachycardia. papaverine hydrochloride is not indicated for the treatment of impotence by intracorporeal injection. the intracorporeal injection of papaverine hydrochloride has been reported to have resulted in persistent priapism requiring medical and surgical intervention. drug dependence resulting from the abuse of many of the selective depressants, includin
papaverine hydrochloride injection, solution
bpi labs llc - papaverine hydrochloride (unii: 23473ec6bq) (papaverine - unii:daa13nkg2q) - papaverine is recommended in various conditions accompanied by spasm of smooth muscle, such as vascular spasm associated with acute myocardial infarction (coronary occlusion), angina pectoris, peripheral and pulmonary embolism, peripheral vascular disease in which there is a vasospastic element, or certain cerebral angiospastic states, and visceral spasm , as in ureteral, biliary, or gastrointestinal colic. intravenous injection of papaverine is contraindicated in the presence of complete atrioventricular heart block. when conduction is depressed, the drug may produce transient ectopic rhythms of ventricular origin, either premature beats or paroxysmal tachycardia. papaverine hydrochloride is not indicated for the treatment of impotence by intracorporeal injection. the intracorporeal injection of papaverine hydrochloride has been reported to have resulted in persistent priapism requiring medical and surgical intervention. drug dependence resulting from the abuse of many of the selective depressants, includi